KM Research Hub
← 返回论文库
无 KM 图 入排:符合 图源:待检查 入排置信度 0.98

Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma.

AnnaLynn M Williams, Angie Mae Rodday, Lindsay A Renfro, Yue Wu, Tara O Henderson, Frank G Keller, Angela Punnett, David Hodgson, Kara M Kelly, Sharon M Castellino, Susan K Parsons

J Natl Cancer Inst 117(10) 2112-2119

PMID40700618
PMCIDPMC12505141
DOI10.1093/jnci/djaf197
发表日期2025-07-23
入排依据:原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。
图像/No. at risk 复核:历史记录没有可审查 Figure,无法确认 KM 曲线与 No. at risk 表。
AI 判定该论文不进入自动 KM 提取:This is a secondary analysis of quality of life trajectories within a phase III trial, not a primary report of the trial's efficacy or safety results.
摘要

摘要

BACKGROUND: Health-related quality of life (HRQoL) was recently demonstrated to improve throughout therapy for high-risk pediatric Hodgkin lymphoma (HL); however, average scores may not reflect individual differences. This study aimed to identify subgroups of patients with similar HRQoL trajectories from pre- to post-therapy. METHODS: AHOD1331 trial participants aged 11-20 (n = 268; mean [SD] age = 15.6 [1.9]; 48% male) completed the Child Health Ratings Inventories-Global scale (HRQoL) prior to treatment, after cycle 2, after cycle 5, and the end of treatment. Group-based trajectory models (GBTMs) identified latent clusters of individuals with similar HRQoL patterns over time. Multivariable multinomial logistic regression estimated the association between a priori defined characteristics and membership in trajectory-based groups. Log-rank tests examined differences in post-T4 progression-free survival (PFS) by trajectory groups. RESULTS: GBTM identified 3 HRQoL groups: Group 1 (consistently unfavorable [25.7%]), Group 2 (moderate-and-increasing [44.8%]), and Group 3 (consistently favorable [29.5%]). Older age (odds ratio = 1.24, 95% confidence interval = 1.03 to 1.50; P = .022), female sex (2.48, 1.23 to 4.99; P = .011), and Hispanic ethnicity (2.31, 0.97 to 5.50; P = .059) were associated with increased odds of membership in Group 1 vs Group 3. Older age (1.18, 1.00 to 1.39; P = .038) and B-symptoms (2.18, 1.09 to 4.33; P = .027) were associated with increased odds of Group 2 membership vs Group 3. Group membership was not associated with post-T4 PFS. CONCLUSIONS: A subgroup of high-risk pediatric HL patients experience persistently poor HRQoL, starting at diagnosis and continuing through therapy. Age, female sex, Hispanic ethnicity, and B-symptoms were linked to worse HRQoL. These findings can help identify patients at higher risk for poor HRQoL and guide intervention. CLINICALTRIALS.GOV: NCT02166463.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。